Market Cap 10.20B
Revenue (ttm) 0.00
Net Income (ttm) -1.08B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,603,100
Avg Vol 4,995,274
Day's Range N/A - N/A
Shares Out 797.75M
Stochastic %K 20%
Beta -1.23
Analysts Sell
Price Target $27.27

Company Profile

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 203 2034
Address:
601 Brickell Key Drive, Suite 1000, Miami, United States
ChillPill1972
ChillPill1972 Aug. 19 at 11:42 AM
$SMMT Its wild Moderna (67%) and Merck (8%) are up massively on a headline their phase 3 skin cancer vaccine + keytruda had good results. No data will be shared until an oncology conference later this fall.
0 · Reply
TruthBroker2
TruthBroker2 Aug. 19 at 1:04 AM
$SMMT !!!
0 · Reply
jobix
jobix Aug. 18 at 9:57 PM
$SMMT WCLC late breaking abstract coming out as from August 19th.Those responsible for this criminal raid soon will be hiding from our billionaire CEO.
1 · Reply
NFA_DYOR
NFA_DYOR Aug. 18 at 6:17 PM
$SMMT Thanks for $12
0 · Reply
NFA_DYOR
NFA_DYOR Aug. 18 at 5:48 PM
$CMPX $SMMT $BEAM $REPL $ENGN Put:call 0 Something cooking
0 · Reply
Boom1166
Boom1166 Aug. 18 at 5:03 PM
0 · Reply
Dom_Ruinart
Dom_Ruinart Aug. 18 at 4:19 PM
$SMMT All eyes on Nov 14 FDA decision. Solid Phase 3 data combined with $100M+ in CEO open-market buys creates a strong asymmetric risk-reward setup heading into Q4.
0 · Reply
TruthBroker2
TruthBroker2 Aug. 18 at 3:13 PM
0 · Reply
Fox94
Fox94 Aug. 18 at 12:58 PM
$SMMT bunch of over reacting. This is why I bought leaps…
1 · Reply
SmokeWagon
SmokeWagon Aug. 18 at 12:22 PM
$SMMT !!!
0 · Reply
Latest News on SMMT
Summit Therapeutics falls -8.5%

2026-08-17T14:05:25.000Z - 1 day ago

Summit Therapeutics falls -8.5%


Summit Therapeutics Earnings Call Transcript: Q2 2026

Jul 23, 2026, 4:30 PM EDT - 26 days ago

Summit Therapeutics Earnings Call Transcript: Q2 2026


Summit Therapeutics Earnings release: Q2 2026

Jul 23, 2026, 4:30 PM EDT - 26 days ago

Summit Therapeutics Earnings release: Q2 2026


Summit Therapeutics Quarterly report: Q2 2026

Jul 23, 2026, 4:30 PM EDT - 26 days ago

Summit Therapeutics Quarterly report: Q2 2026


Summit Therapeutics Slides: Q2 2026

Jul 23, 2026, 4:30 PM EDT - 26 days ago

Summit Therapeutics Slides: Q2 2026


Summit Therapeutics reports Q2 EPS (28c), consensus (21c)

2026-07-23T20:10:46.000Z - 26 days ago

Summit Therapeutics reports Q2 EPS (28c), consensus (21c)


Summit Therapeutics Transcript: AGM 2026

Jun 10, 2026, 8:30 AM EDT - 2 months ago

Summit Therapeutics Transcript: AGM 2026


The Era of the One-Size-Fits-All Cancer Drug Is Ending

Jun 6, 2026, 5:30 AM EDT - 2 months ago

The Era of the One-Size-Fits-All Cancer Drug Is Ending


Summit Therapeutics Transcript: Status update

Jun 1, 2026, 7:00 AM EDT - 2 months ago

Summit Therapeutics Transcript: Status update


Summit Therapeutics Press release: Status update

Jun 1, 2026, 7:00 AM EDT - 2 months ago

Summit Therapeutics Press release: Status update


Summit Therapeutics Slides: Status update

Jun 1, 2026, 7:00 AM EDT - 2 months ago

Summit Therapeutics Slides: Status update


Summit Therapeutics Earnings release: Q1 2026

Apr 30, 2026, 4:00 PM EDT - 3 months ago

Summit Therapeutics Earnings release: Q1 2026


Summit Therapeutics Quarterly report: Q1 2026

Apr 30, 2026, 4:00 PM EDT - 3 months ago

Summit Therapeutics Quarterly report: Q1 2026


Summit Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics to Present at Upcoming Investor Conferences

Feb 26, 2026, 6:45 PM EST - 6 months ago

Summit Therapeutics to Present at Upcoming Investor Conferences


Summit Therapeutics Earnings Call Transcript: Q4 2025

Feb 23, 2026, 4:30 PM EST - 6 months ago

Summit Therapeutics Earnings Call Transcript: Q4 2025


Summit Therapeutics Annual report: Q4 2025

Feb 23, 2026, 4:30 PM EST - 6 months ago

Summit Therapeutics Annual report: Q4 2025


Summit Therapeutics Earnings release: Q4 2025

Feb 23, 2026, 4:30 PM EST - 6 months ago

Summit Therapeutics Earnings release: Q4 2025


Summit Therapeutics Slides: Q4 2025

Feb 23, 2026, 4:30 PM EST - 6 months ago

Summit Therapeutics Slides: Q4 2025


Summit Therapeutics Raises $500 Million in Private Placement

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Raises $500 Million in Private Placement


Summit Therapeutics Earnings Call Transcript: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Earnings Call Transcript: Q3 2025


Summit Therapeutics Earnings release: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Earnings release: Q3 2025


Summit Therapeutics Quarterly report: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Quarterly report: Q3 2025


Summit Therapeutics Slides: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Slides: Q3 2025


Summit Therapeutics Inc. Investigated by the Portnoy Law Firm

Sep 16, 2025, 4:31 PM EDT - 1 year ago

Summit Therapeutics Inc. Investigated by the Portnoy Law Firm


Summit Therapeutics Transcript: Study Update

Sep 8, 2025, 8:00 AM EDT - 1 year ago

Summit Therapeutics Transcript: Study Update


Summit Therapeutics Press release: Study Update

Sep 8, 2025, 8:00 AM EDT - 1 year ago

Summit Therapeutics Press release: Study Update


Summit Therapeutics Slides: Study Update

Sep 8, 2025, 8:00 AM EDT - 1 year ago

Summit Therapeutics Slides: Study Update


Summit Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 1 year ago

Summit Therapeutics Earnings release: Q2 2025


Summit Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 1 year ago

Summit Therapeutics Quarterly report: Q2 2025


ChillPill1972
ChillPill1972 Aug. 19 at 11:42 AM
$SMMT Its wild Moderna (67%) and Merck (8%) are up massively on a headline their phase 3 skin cancer vaccine + keytruda had good results. No data will be shared until an oncology conference later this fall.
0 · Reply
TruthBroker2
TruthBroker2 Aug. 19 at 1:04 AM
$SMMT !!!
0 · Reply
jobix
jobix Aug. 18 at 9:57 PM
$SMMT WCLC late breaking abstract coming out as from August 19th.Those responsible for this criminal raid soon will be hiding from our billionaire CEO.
1 · Reply
NFA_DYOR
NFA_DYOR Aug. 18 at 6:17 PM
$SMMT Thanks for $12
0 · Reply
NFA_DYOR
NFA_DYOR Aug. 18 at 5:48 PM
$CMPX $SMMT $BEAM $REPL $ENGN Put:call 0 Something cooking
0 · Reply
Boom1166
Boom1166 Aug. 18 at 5:03 PM
0 · Reply
Dom_Ruinart
Dom_Ruinart Aug. 18 at 4:19 PM
$SMMT All eyes on Nov 14 FDA decision. Solid Phase 3 data combined with $100M+ in CEO open-market buys creates a strong asymmetric risk-reward setup heading into Q4.
0 · Reply
TruthBroker2
TruthBroker2 Aug. 18 at 3:13 PM
0 · Reply
Fox94
Fox94 Aug. 18 at 12:58 PM
$SMMT bunch of over reacting. This is why I bought leaps…
1 · Reply
SmokeWagon
SmokeWagon Aug. 18 at 12:22 PM
$SMMT !!!
0 · Reply
LeisureSuitLarry
LeisureSuitLarry Aug. 18 at 12:14 PM
0 · Reply
My_Lai_1968
My_Lai_1968 Aug. 18 at 7:10 AM
$SMMT My dad just called and said he might buy some shares of Summit.
0 · Reply
Caydawg
Caydawg Aug. 17 at 10:39 PM
$SMMT what’s a realstic date we can shoot for to get back into the twenty’s?
2 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 8:20 PM
0 · Reply
DayTradingPredictions
DayTradingPredictions Aug. 17 at 7:53 PM
$SMMT smmt eod
0 · Reply
Winttard
Winttard Aug. 17 at 7:01 PM
$SMMT what article. I dont see it anywhere?
3 · Reply
UltimoDaBaggie
UltimoDaBaggie Aug. 17 at 6:50 PM
$SMMT I researched it. Total BS. Would take too long to explain. Glad I bought more this AM
4 · Reply
CoconutTrader3000
CoconutTrader3000 Aug. 17 at 6:43 PM
$SMMT Updated label shows degradation in PFS. Not sure how serious it is or not. Biospace has an article but won't give numbers. "But as part of the approval, the NMPA posted some new data on the drug’s label showing degradation of progression free survival (PFS) in the Phase 3 HARMONi-6 trial that underpinned the regulatory clearance." Anybody get actual numbers on the degradation being reported?
0 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 6:35 PM
$SMMT The hit piece for the 14.5 puts is out .
0 · Reply
GeneMachine
GeneMachine Aug. 17 at 5:49 PM
$SMMT having missed the opportunity to take profit in the 15s twice previously, I took profit this time last week. Now with the potential FDA delay, fresh new ATM, unusual puts, and 40% to 28% risk reduction label, I'm not sure where to re-enter. I'm not good enough at this and might miss the opportunity. Thoughts on fair entry levels? I'm not a buyer from 1 or 2 dollars, so it's not easy to hold if it keeps dropping.
1 · Reply
TruthBroker2
TruthBroker2 Aug. 17 at 5:44 PM
$SMMT China 🤣
1 · Reply
cowneck_trader
cowneck_trader Aug. 17 at 5:41 PM
$SMMT what the hell is going on in China?
1 · Reply